iRadimed Corporation (IRMD) vs SiBone (SIBN)

iRadimed Corporation and SiBone are both Medical Devices companies. iRadimed Corporation and SiBone are of similar size ($1.1B and $1.1B). SiBone has negative trailing earnings, so its P/E is not meaningful; iRadimed Corporation trades at 44.9×. SiBone grew revenue faster over the last twelve months: 14.0% against 11.0%. iRadimed Corporation has the higher net margin (26.9% vs −6.20%) and the higher return on invested capital (41.8% vs −14.1%). Across the 19 metrics below, iRadimed Corporation leads on 12 and SiBone on 7.

Valuation

Metric IRMD SIBN Medical Devices median
P/E 44.90 n/m 25.58
P/S 12.15 4.92 2.54
P/B 10.19 5.88 2.48
Price to free cash flow 44.05 n/m 28.81
EV/EBITDA 33.49 n/m 11.51
EV/Sales 11.44 4.43 2.72
Earnings yield 2.23% (1.28%) (12.82%)
Free cash flow yield 2.27% (0.39%) (8.18%)

Profitability

Metric IRMD SIBN Medical Devices median
Gross margin 75.51% 79.40% 57.76%
Operating margin 32.30% (7.57%) (15.07%)
Net margin 26.85% (6.20%) (14.45%)
Free cash flow margin 28.66% (1.90%) (3.88%)
Return on equity 23.42% (7.67%) (10.35%)
Return on assets 20.34% (5.57%) (17.26%)
Return on invested capital 41.79% (14.10%) (5.27%)

Growth

Metric IRMD SIBN Medical Devices median
Revenue growth (TTM) 10.97% 13.99% 10.41%
EPS growth (last fiscal year) 16.67% 41.33% 28.17%
Revenue growth, 5-year CAGR 21.45% 22.32% 15.74%
Net income growth, 5-year CAGR 75.02% 0.00% 0.00%

Health

Metric IRMD SIBN Medical Devices median
Debt to equity 0.00 0.19 0.04
Current ratio 8.99 7.58 2.74
Net debt to EBITDA (1.87) 5.76 0.54

Dividend

Metric IRMD SIBN Medical Devices median
Dividend yield 0.91% — 1.02%
Payout ratio 0.41 — 0.37

Size

Metric IRMD SIBN Medical Devices median
Market cap 1.09b 1.09b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack